Dietary Supplement
Palmitoylethanolamide (PEA)
Palmitoylethanolamide (PEA) is a dietary supplement with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
60%
Ph not_applicable
2
40%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Completed(1)
Detailed Status
Not yet recruiting2
Recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (60.0%)
N/A2 (40.0%)
Trials by Status
completed120%
not_yet_recruiting240%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable
Palmitoylethanolamide in Ulcerative Colitis
NCT07609810
recruitingphase_2
Sleep and Stress Study
NCT07315516
not_yet_recruitingnot_applicable
Palmitoylethanolamide vs Ibuprofen for Pain After ESWL
NCT07316660
recruitingphase_2
Long-Term PEA Safety Study
NCT06717867
completedphase_2
A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression
NCT06229977
Clinical Trials (5)
Showing 5 of 5 trials
NCT07609810Not Applicable
Palmitoylethanolamide in Ulcerative Colitis
NCT07315516Phase 2
Sleep and Stress Study
NCT07316660Not Applicable
Palmitoylethanolamide vs Ibuprofen for Pain After ESWL
NCT06717867Phase 2
Long-Term PEA Safety Study
NCT06229977Phase 2
A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression
All 5 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 5